欧洲鼻腔喷雾剂市场 – 行业趋势及 2030 年预测

欧洲鼻腔喷雾剂市场分析与洞察

过敏性鼻炎是全球五亿多人的主要健康问题。全球近一半的患者会出现鼻塞、打鼾、鼻后滴漏、咳嗽、嗅觉减退、头痛等症状，持续数月或数年。这些症状还会影响患者的生活质量。

鼻腔喷雾器是一种广泛用于鼻腔给药的系统，可治疗主要过敏问题，如鼻塞、感染、眼睛发痒或流泪、流鼻涕、胸闷、咳嗽、喘息、呼吸困难、浅呼吸等。其他一些疾病还包括鼻息肉、炎症性肠病、肾脏相关问题等。借助喷雾器通过鼻腔给药是一种非侵入性技术，可让药物在患者体内快速起效。鼻腔喷雾器是最具成本效益的喷雾器之一，不需要侵入，易于使用和自行给药，患者依从性高。因此，鼻腔给药是近年来流行的给药途径之一，并具有强大的增长机会。

鼻腔喷雾剂在市场上有非处方药 (OTC) 或处方药两种形式，用于治疗鼻部疾病，如鼻部过敏、鼻塞或鼻塞、慢性鼻窦炎、过敏性鼻炎和其他与鼻子相关的问题。这些喷雾剂在市场上有泵装或罐装两种形式。

Data Bridge Market Research 分析称，到 2030 年，欧洲鼻腔喷雾剂市场价值预计将达到 98.5526 亿美元，预测期内的复合年增长率为 6.5%。

Market Definition

Nasal sprays are devices that help in the delivery of the drug through the nose in the nasal cavity to treat allergies and other problems related to brain inflammation, diabetes, dental problems, and the central nervous system. Allergy is a condition in which the immune system of the body reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients.

There are different types of nasal spray available in the market, such as decongestion nasal spray, saline nasal spray, and steroid nasal spray. Decongestants are devices with drugs for the treatment of nasal congestion and provide short-term relief from a blocked nose. The decongestion nasal spray consists of drugs that open up the airways of the nasal part and helps in the breathing process.

During the cold and dry winter season, saline nasal sprays are used to avoid problems related to a stuffy nose. These devices are used to treat sinusitis, nasal crusting, and thin secretions of liquid from the nose, which are formed due to bacterial infection and lead to the dryness of the nasal area. This device helps in cleaning the nasal passage and mucus present in that area due to cold.

Europe Nasal Spray Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

DRIVER

• Increase in Infection and Allergic Cases

Allergy is a condition that makes the immune system weaken, and the immune system reacts abnormally to a foreign substance. Allergies have many forms, such as Allergic Rhinitis (AR), and this affects nearly 40 to 50 million people in the U.S. Some allergies may interfere with day-to-day activities and the quality of life.

Due to the increase in population, urbanization, and industrialization has increased tremendously, which has led to a rise in allergen. This allergen is responsible for allergies or infectious diseases in many people.

Thus, the rise in the prevalence of allergic diseases such as AR has led to an increase in the demand for nasal sprays, which is expected to drive market growth in the coming years.

RESTRAINT

• Adverse Effects of Using Nasal Sprays

Many people opt for nasal sprays in order to get relief from a runny and stuffy nose, but using a nasal spray for a longer period of time causes several side effects. Steroid nasal sprays, also called corticosteroid nasal sprays, are anti-inflammatory medicines that are sprayed into the nose. They can be used to treat a range of conditions, including hay fever, sinusitis, non-allergic rhinitis, and nasal polyps. Some steroid nasal sprays are available to buy from pharmacies and shops, while others are only available on prescription.

Using nasal sprays for a prolonged period of time can lead to bleeding from the nose and even headaches. Some may experience other side effects, such as addiction or even congestion.

If one is taking a high dose for a long time, there is also a small chance one could get some of the side effects of steroid tablets, such as increased appetite, mood changes, and difficulty sleeping.

Thus, the adverse effects of nasal sprays are expected to restrain the market growth.

OPPORTUNITY

• Expanding Therapeutic Applications for Nasal Sprays

Intranasal administration provides various useful options for the local and systemic delivery of diverse therapeutic agents for the treatment of problems such as allergies, respiratory diseases, and many others.

A nasal spray is one of the recently developed products, such as OptiNose and ViaNase, that helps to enable the targeting of formulations to a specific area of the site in the nasal cavity in humans.

Nasal therapy has been known as a form of treatment in Indian medicine for decades. It is also called “NASAYA KARMA” in Ayurvedic systems in Indian medicine.

The nasal spray consists of one or more than one therapeutically active ingredients in the form of suspension or solution in a non-pressurized dispenser. The most common allergy is AR.

Apart from respiratory problems, there are other therapeutic areas such as orthopedic, renal, and many other areas, where the nasal spray is playing important role in treating and curing such problems. In the future, other treatments may be developed that can help in the treatment of other problems easily.

CHALLENGE

• Regulatory Hurdles

Nasal drug delivery can be evaluated by many regulatory agencies, such as the U.S. FDA and the European Medicines Agency (EMA). These agencies provide a set of guidelines and regulations for any product before it is launched in the market. They allow performing various in vitro test methods for determining the characterization of nasal drug products and that should come in an acceptable range as given by such regulatory bodies.

Nasal spray can be designed as per the dose requirement of drug substances for patients suffering from nasal or any other issues. Some aspects of nasal sprays may be exceptional in the case of formulation, manufacturing, container closure system, stability, controls of critical steps, intermediates, and drug products. These aspects should be measured carefully while developing a program of nasal spray. Because of these changes ability of the product to treat patients may get affected.

Strict rules and regulations for the product for nasal spray manufacturing are more challenging for the manufacturer to get approval from regulatory agencies. The spray characteristics can be influenced by the design of the device, and by the handling of the device. Performing such tests to get the perfect result, that is, an acceptable range as given by the regulatory body, is more challenging in nasal spray manufacturing.

Post-COVID-19 Impact Analysis on the Europe Nasal Spray Market

COVID-19 had a significant impact on the generic drug market for inhalation and nasal spray, as one of the main symptoms associated with COVID-19 is shortness of breath. The demand for inhalation and nasal spray increased during the pandemic.

For instance,

• According to a MedComm journal article published in 2021, nasal sprays demonstrated the ability to be an effective COVID-19 treatment and vaccine option

Spray formulations that may inactivate SARS-CoV-2 or restrict its entry into cells were thought to be beneficial in preventing viral spread to the lungs or surrounding people. Relaxed lockdowns and the resumption of healthcare practices are expected to accelerate market growth in the post-pandemic era. COVID-19 patients are still experiencing long-term side effects such as shortness of breath.

Recent Developments

• In January 2023, Viatris Inc. (NASDAQ: VTRS), a Europe healthcare company, today announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. This acquisition would help the company in its business expansion.
• In March 2023, Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd, announced the launch of additional strengths for the generic version of Revlimid1 (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the U.S. This product launch would help the company in its product portfolio expansion.

Europe Nasal Spray Market Scope

根据产品类型、容器设计、剂型、治疗类别、应用、处方/可用性和最终用户，欧洲鼻喷雾剂市场可分为七个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

产品类型

• 鼻塞缓解喷雾剂
• 类固醇鼻腔喷雾剂
• 盐水溶液/盐水鼻腔喷雾剂
• 其他的

根据产品类型，市场分为减充血鼻喷雾剂、盐水溶液/盐水鼻喷雾剂、类固醇鼻喷雾剂等。

容器设计

• 泵瓶
• 加压罐

根据容器设计，市场分为压力罐和泵瓶。

剂型

• 多剂量
• 单位/单剂量
• 双剂量

根据剂型，市场分为单位/单剂量、双剂量和多剂量。

治疗类

• 抗组胺药
• 鼻用类固醇
• 肥大细胞抑制剂
• 抗胆碱能

根据治疗类别，市场分为抗组胺药、鼻用类固醇、肥大细胞抑制剂和抗胆碱能药物。

应用

• 鼻塞
• 过敏性和非过敏性鼻炎
• 中枢神经系统疾病
• 疫苗接种
• 其他的

根据应用，市场分为鼻塞、过敏性和非过敏性鼻炎、中枢神经系统疾病、疫苗接种等。

处方/可用性

• 在柜台
• 处方

根据处方/可用性，市场分为非处方药和处方药。

最终用户

• 家庭护理环境
• 医院
• 诊所
• 社区卫生保健

根据最终用户，市场分为家庭护理环境、医院、诊所和社区医疗保健。

欧洲鼻腔喷雾剂市场区域分析/见解

欧洲鼻腔喷雾剂市场根据产品类型、容器设计、剂型、治疗类别、应用、处方/可用性和最终用户分为七个显著的部分。

本市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、瑞士、荷兰、比利时、俄罗斯、土耳其和欧洲其他国家。

2023 年，德国将主导欧洲鼻腔喷雾剂市场，因为欧洲最大的消费市场和高 GDP 市场中拥有主要市场参与者。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。

竞争格局和欧洲鼻腔喷雾剂市场份额分析

欧洲鼻喷雾剂市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。

欧洲鼻腔喷雾剂市场的一些主要市场参与者包括 EMERGENT、Cipla Inc.、Sandoz International GmbH（诺华旗下子公司）、Aytu Health（Aytu BioPharma, Inc. 的子公司）、Bayer AG、GlaxoSmithKline plc.、Assertio Therapeutics, Inc.、Aurena Laboratories.、J Pharmaceuticals、St. Renatus.、Ultratech India Limited、Catalent, Inc.、Teva Pharmaceuticals USA, Inc.（Teva Pharmaceutical Industries Ltd 的子公司）、Pfizer Inc.、Viatris Inc.、LEEFORD HEALTHCARE LTD 和 Aishwarya Group 等。

SKU-26832